MONICA OLAGUE: Open Payments
NPI 1013539287 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 20 payments from 7 companies in 2025. Trend: 2023 $560 · 2024 $216 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $308 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, GEMTESA, MOUNJARO, SHINGRIX, CAPVAXIVE, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, EVENITY.
Industry payments across TX — which companies pay providers there.
